• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Galapagos NV - Articles and news items

Galapagos completes recruitment for ORIGIN Phase 2 trial with GLPG1205 in ulcerative colitis patients

Industry news / 18 June 2015 / Victoria White

Galapagos has completed recruitment for the Phase 2 Proof-of-Concept study in ulcerative colitis with GPR84 inhibitor GLPG1205…

 

Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionWATCH NOW
+ +